CISATRACURIUM OMEGA SINGLE DOSE SOLUTION Canada - English - Health Canada

cisatracurium omega single dose solution

omega laboratories limited - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

CISATRACURIUM OMEGA MULTIDOSE SOLUTION Canada - English - Health Canada

cisatracurium omega multidose solution

omega laboratories limited - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

CISATRACURIUM BESYLATE INJECTION SOLUTION Canada - English - Health Canada

cisatracurium besylate injection solution

pfizer canada ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

Cisatracurium APOTEX cisatracurium (as besilate) 5 mg / 2.5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 5 mg / 2.5 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium APOTEX cisatracurium (as besilate) 10 mg / 5 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 10 mg / 5 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Cisatracurium APOTEX cisatracurium (as besilate) 20 mg / 10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium apotex cisatracurium (as besilate) 20 mg / 10 ml solution for injection ampoule

arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

CISATRACURIUM BESYLATE INJECTION SOLUTION Canada - English - Health Canada

cisatracurium besylate injection solution

mylan pharmaceuticals ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE) SOLUTION Canada - English - Health Canada

cisatracurium besylate injection (preservative-free) solution

mylan pharmaceuticals ulc - cisatracurium (cisatracurium besylate) - solution - 2mg - cisatracurium (cisatracurium besylate) 2mg - neuromuscular blocking agents

CISATRACURIUM PFIZER cisatracurium (as besilate) 20 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium pfizer cisatracurium (as besilate) 20 mg/10 ml solution for injection ampoule

pfizer australia pty ltd - cisatracurium besilate -

Cisatracurium besilate 150mg/30ml solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cisatracurium besilate 150mg/30ml solution for injection vials

pfizer ltd - cisatracurium besilate - solution for injection - 5mg/1ml